| 영문 | alcohol | 한글 | 알코올 |
|---|---|---|---|
| 설명 | 대개 에탄올(ethanol, ethyl alcohol)을 지칭하는 말이다. 물과 같이 맑은 색이지만 특이한 냄새가 있고 끓는 점이 낮은 액체이다. 농도가 높은 것은 의료용 또는 소독제로 쓰이고 낮은 농도로 된 것은 음료(술)로도 이용된다. |
||
| 영문 | ethyl alcohol | 한글 | 에틸알코올 |
|---|---|---|---|
| 설명 | 지방족 포화알코올의 하나. 각종 알코올 음료 속에 함유되어 있어 주정이라고도 하고, 또 에탄올이라고도 한다. 보통 알코올이라고 하면 이 에틸알코올을 가리킨다. 술의 성분으로서 예전부터 알려져 있었으나, 술이 취하는 원인이 에탄올에 있다는 것을 안 것은 15세기 이후의 일이다. 조성은 처음에 라부아지에나 N.T. 소슈르 등에 의해 측정되고, 게이뤼삭이나 J.B. 뒤마 등에 의해서 확정되었다. 알코올이라는 이름은 원래 눈썹에 칠하는 흑색 안료顔料를 가리키는 아라비아어였는데. 이것의 미소분말을 만드는데 승화법을 사용한 데서 술을 증류하여 가연성 엑스를 만드는 것으로 전화轉化하고, 이것이 다시 증류물을 가리키는 말이 되었다. 알코올이라는 말이 에탄올을 가리키게 되고, 다시 알코올 전반을 가리키게 된 것은 19세기 이후의 일이다. 에탄올을 복용하면 대뇌의 제어기능이 억제되어 흥분상태가 되고, 이어서 중추신경이 억제된다. 무색투명한 휘발성 액체. 특유한 냄새와 맛을 가지며, 인체에 흡수되면 흥분이나 마취 작용을 일으킨다. 화학약품의 합성 원료, 용제, 연료, 알코올성 음료 따위로 쓴다. 알코올은 간세포에 존재하는 알코올탈수소효소(alcohol dehydrogenase)가 대사한다. 급성 중독 증상은 혈중 알코올 농도와 비례한다. 혈중 알코올 농도가 높아질수록 중추신경계는 억제되어 혈중 농도가 3.5~4.5mg/mL이면 혼수에 빠져 사망할 수도 있다. |
||
| 영문 | fetal alcohol syndrome | 한글 | 태아알코올증후군 |
|---|---|---|---|
| 설명 | 임신기간 중 만성적으로 알코올을 섭취한 여자에게서 태어난 영아에게 나타나는 형태발생의 이상을 나타내는 증후군으로서 위턱뼈발육부전, 앞머리와 아래턱의 돌출, 짧은검열, 작은안구증, 눈구석주름, 심한 성장지연, 정신지체 등을 나타낸다. |
||
| CAS | calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car... |
|---|---|
| CuS | copper supplement |
| ECGS | endothelial cell growth supplement |
| GIS | gas in stomach; gastrointestinal series; geographic information system; guaranteed income supplement... |
| HCTS | high cholesterol and tocopherol supplement |
| ECGS | Endothelial Cell Growth Supplement |
|---|---|
| JAMA | Journal of the American Medical Association |
| NEJM | New England Journal of Medicine |
| CES-D | Center for Epidemiologic Studies - Depression |
| CES-D | Center for Epidemiologic Studies - Depression Scale |
| supplement | Something that supplies a want or make an addition: something that completes, adds a finishing touch or brings closer to completion or a desired state. (18 Nov 1997) |
|---|---|
| journal article | The predominant publication type for articles and other items indexed for nlm databases. (12 Dec 1998) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
| sampling studies | Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled. (12 Dec 1998) |
| prospective studies | Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. (12 Dec 1998) |
| his bundle studies | <cardiology> This test studies the electrical activity of the bundle of HIS. The bundle of HIS is a group of electrical fibres in the heart that are responsible for transmitting the electrical impulses which generate a normal cardiac contraction. This test may be performed in cases of cardiac arrhythmias, to locate a specific area responsible for a conduction defect and to determine the need for cardiac pacemaker placement. The test involves the passage of a an electrode tipped catheter into the heart. This catheter is usually threaded through a neck, arm or chest vein. Measurements of the HIS bundle can then be performed while standard ECG leads are placed on the arms and legs. This test carries a small risk of bleeding, arrhythmias, embolism, heart attack and stroke. It is performed by a specially trained cardiologist. (27 Sep 1997) |
| immunofluorescent studies | <technique> A special assay that relies on the production of measurable fluorescent light. An immunofluorescent tagged antibody interacts and binds with an antigen allowing an indirect measurement of its concentration. (27 Sep 1997) |
| intervention studies | Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|